Please login or register.

Login with username, password and session length
Advanced search  

News:

Follow us on Twitter and Facebook

media

Author Topic: Is it safe to take conti hrt and vagifem?  (Read 2774 times)

Nickyp

  • Member
  • *
  • Posts: 68
Is it safe to take conti hrt and vagifem?
« on: November 18, 2017, 10:41:34 PM »

I am on a conti hrt and have been for two years. My doctor has recently prescribed vagifem for va. reading some of the posts I'm confused about if it is safe to use both. My doc just left a prescription for me to collect and said if I wanted to discuss then to see her. I can't get an appointment until December so in the meantime can anyone help. Also what is meant by systemic hrt and is vagifem something that I will need to keep taking, or do I stop if the symptoms disappear. Finding this all very confusing, seem to fix one thing to find a problem with something else !
Logged

Lanzalover

  • Member
  • *
  • Posts: 600
Re: Is it safe to take conti hrt and vagifem?
« Reply #1 on: November 18, 2017, 11:24:18 PM »

Hi Nickyp

Yes it is perfectly fine to use both and you will need to use Vagifem all the time to treat VA for the first two weeks you need to use it every night then after the initial two weeks  2 or 3 times a week as a maintenance dose VA does not get better you need to use it forever.
Systemic HRT is the conti HRT you are using.
There are lots of ladies on here using both so please don't worry.

Lanzalover x
Logged

Nickyp

  • Member
  • *
  • Posts: 68
Re: Is it safe to take conti hrt and vagifem?
« Reply #2 on: November 19, 2017, 09:47:57 AM »

Thanks for the reply, much appreciated.
Logged

Dancinggirl

  • Member
  • *
  • Posts: 7091
Re: Is it safe to take conti hrt and vagifem?
« Reply #3 on: November 19, 2017, 10:37:37 AM »

Yes, yes, yes - you can definitely use local and systemic HRt together.

Here is the section from the NICE guidelines that you could print off and show your GP:

Urogenital atrophy
1.4.9
Offer vaginal oestrogen to women with urogenital atrophy (including those on systemic HRT) and continue treatment for as long as needed to relieve symptoms.
1.4.10
Consider vaginal oestrogen for women with urogenital atrophy in whom systemic HRT is contraindicated, after seeking advice from a healthcare professional with expertise in menopause.
1.4.11
If vaginal oestrogen does not relieve symptoms of urogenital atrophy, consider increasing the dose after seeking advice from a healthcare professional with expertise in menopause.
1.4.12
Explain to women with urogenital atrophy that:
symptoms often come back when treatment is stopped
adverse effects from vaginal oestrogen are very rare
they should report unscheduled vaginal bleeding to their GP.

1.4.13
Advise women with vaginal dryness that moisturisers and lubricants can be used alone or in addition to vaginal oestrogen.
1.4.14
Do not offer routine monitoring of endometrial thickness during treatment for urogenital atrophy.


DG x
Logged